Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union
Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU). A Steering Commi...
Uloženo v:
| Vydáno v: | The journal of clinical endocrinology and metabolism Ročník 100; číslo 4; s. 1245 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.04.2015
|
| Témata: | |
| ISSN: | 1945-7197, 1945-7197 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.
The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU).
A Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data.
Expert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs.
EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs. |
|---|---|
| AbstractList | Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.CONTEXTRapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU).OBJECTIVEThe objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU).A Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data.DESIGNA Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data.Expert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs.RESULTSExpert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs.EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.CONCLUSIONSEDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs. Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. The objective was to quantify a range of health and economic costs that can be reasonably attributed to EDC exposures in the European Union (EU). A Steering Committee of scientists adapted the Intergovernmental Panel on Climate Change weight-of-evidence characterization for probability of causation based upon levels of available epidemiological and toxicological evidence for one or more chemicals contributing to disease by an endocrine disruptor mechanism. To evaluate the epidemiological evidence, the Steering Committee adapted the World Health Organization Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria, whereas the Steering Committee adapted definitions recently promulgated by the Danish Environmental Protection Agency for evaluating laboratory and animal evidence of endocrine disruption. Expert panels used the Delphi method to make decisions on the strength of the data. Expert panels achieved consensus at least for probable (>20%) EDC causation for IQ loss and associated intellectual disability, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median cost of €157 billion (or $209 billion, corresponding to 1.23% of EU gross domestic product) annually across 1000 simulations. Notably, using the lowest end of the probability range for each relationship in the Monte Carlo simulations produced a median range of €109 billion that differed modestly from base case probability inputs. EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs. |
| Author | Hauser, Russ Hass, Ulla Zoeller, R Thomas Kortenkamp, Andreas Skakkebaek, Niels E Trasande, Leonardo Bellanger, Martine DiGangi, Joseph Legler, Juliette Grandjean, Philippe Myers, John Peterson Heindel, Jerrold J |
| Author_xml | – sequence: 1 givenname: Leonardo surname: Trasande fullname: Trasande, Leonardo organization: New York University (NYU) School of Medicine (L.T.), New York, New York 10016; NYU Wagner School of Public Service (L.T.), New York, New York 10012; NYU Steinhardt School of Culture, Education, and Human Development (L.T.), Department of Nutrition, Food & Public Health, New York, New York 10003; NYU Global Institute of Public Health (L.T.), New York, New York 10003; University of Massachusetts (R.T.Z.), Amherst, Massachusetts 01003; National Food Institute (U.H.), Technical University of Denmark, 19 2860 Søborg, Denmark; Brunel University (A.K., R.H.), Institute of Environment, Health and Societies, Uxbridge, Middlesex UB8 3PH, United Kingdom; Department of Environmental Health (P.G.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115; University of Southern Denmark (P.G.), 5000 Odense, Denmark; Environmental Health Sciences (J.P.M.), Charlottesville, Virginia 22902; IPEN (J.D.), SE-402 35 Gothenburg, Sweden; EHESP School of Public Health (M.B.), 75014 Paris, France; Department of Chemistry and Biology (J.L.), Institute for Environmental Studies, VU University, 1081 HV Amsterdam, The Netherlands; Department of Growth and Reproduction (N.E.S.), Rigshospitalet, Endocrine Disruption of Male Reproduction and Child Health (EDMaRC) and University of Copenhagen, DK-2100 Copenhagen, Denmark; and National Institute of Environmental Health Sciences (J.J.H.), Division of Extramural Research and Training, Research Triangle Park, North Carolina 27709 – sequence: 2 givenname: R Thomas surname: Zoeller fullname: Zoeller, R Thomas – sequence: 3 givenname: Ulla surname: Hass fullname: Hass, Ulla – sequence: 4 givenname: Andreas surname: Kortenkamp fullname: Kortenkamp, Andreas – sequence: 5 givenname: Philippe surname: Grandjean fullname: Grandjean, Philippe – sequence: 6 givenname: John Peterson surname: Myers fullname: Myers, John Peterson – sequence: 7 givenname: Joseph surname: DiGangi fullname: DiGangi, Joseph – sequence: 8 givenname: Martine surname: Bellanger fullname: Bellanger, Martine – sequence: 9 givenname: Russ surname: Hauser fullname: Hauser, Russ – sequence: 10 givenname: Juliette surname: Legler fullname: Legler, Juliette – sequence: 11 givenname: Niels E surname: Skakkebaek fullname: Skakkebaek, Niels E – sequence: 12 givenname: Jerrold J surname: Heindel fullname: Heindel, Jerrold J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25742516$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLxDAURoOMOA_duZYs3XRs0qRpljKMDxhwo-uSpjczGaZJTRrQf2_wAa7uhXvuB99ZopnzDhC6JuWaUFLeHfWaloQVrKLsDC2IZLwQRIrZv32OljEey4wxXl2gOeWCUU7qBdpv42QHNVm3x10KPTisXI97G0FFwNrHKWJvMHyMPqYAePIYXO91sA6KjIU0fj_rAwxWq1PE1uHpAHibgh9BOZyc9e4SnZt8hKvfuUJvD9vXzVOxe3l83tzvCs2bpimkJmVnOg5MKGVETQ3pDJVAJOjcD8CwuqJQMS5MA8ooQzTUIKQSjAhO6Ard_uSOwb8niFM72KjhdFIOfIotqUW2VktRZvTmF03dAH07hiwifLZ_cugXsvppig |
| CitedBy_id | crossref_primary_10_1016_j_jenvman_2024_122108 crossref_primary_10_1080_19338244_2018_1535480 crossref_primary_10_1016_j_scitotenv_2018_03_003 crossref_primary_10_1016_j_cotox_2019_10_006 crossref_primary_10_1038_s41574_025_01098_9 crossref_primary_10_1186_s12940_019_0454_x crossref_primary_10_1289_EHP1774 crossref_primary_10_1016_j_aquatox_2022_106095 crossref_primary_10_1038_pr_2017_168 crossref_primary_10_1210_jendso_bvae083 crossref_primary_10_1007_s41745_022_00319_8 crossref_primary_10_1016_j_ijheh_2023_114311 crossref_primary_10_1016_S2213_8587_20_30128_5 crossref_primary_10_1074_jbc_RA119_011138 crossref_primary_10_3390_ijerph14101158 crossref_primary_10_1016_j_envres_2024_119836 crossref_primary_10_1016_j_envint_2025_109518 crossref_primary_10_1016_j_etap_2016_09_010 crossref_primary_10_3390_ijms22052540 crossref_primary_10_1002_mrd_23116 crossref_primary_10_1016_j_chemosphere_2017_10_084 crossref_primary_10_1016_j_scp_2015_08_001 crossref_primary_10_3390_toxics12080541 crossref_primary_10_1186_s12940_023_01039_x crossref_primary_10_1210_en_2018_00056 crossref_primary_10_1016_j_envint_2018_02_029 crossref_primary_10_3389_fped_2021_705395 crossref_primary_10_1289_EHP378 crossref_primary_10_3389_fendo_2019_00033 crossref_primary_10_1080_00036846_2018_1494803 crossref_primary_10_1016_j_scitotenv_2019_01_255 crossref_primary_10_1016_j_scitotenv_2020_144517 crossref_primary_10_1016_j_envres_2022_113609 crossref_primary_10_1016_j_jhazmat_2024_136506 crossref_primary_10_1007_s11154_016_9334_7 crossref_primary_10_1007_s00204_017_1985_y crossref_primary_10_1038_s41574_023_00872_x crossref_primary_10_1016_j_ijheh_2016_05_001 crossref_primary_10_1016_j_chemosphere_2022_136333 crossref_primary_10_1155_2016_8765049 crossref_primary_10_3390_toxics11020121 crossref_primary_10_1002_etc_3486 crossref_primary_10_1097_GCO_0000000000000722 crossref_primary_10_3390_su11174785 crossref_primary_10_1093_humrep_dev292 crossref_primary_10_1016_j_scitotenv_2020_136570 crossref_primary_10_1016_j_envint_2016_01_021 crossref_primary_10_3390_ijerph182413047 crossref_primary_10_1016_j_jclinepi_2018_11_024 crossref_primary_10_1016_S2213_8587_16_30275_3 crossref_primary_10_1007_s00429_020_02089_4 crossref_primary_10_1093_humrep_dead230 crossref_primary_10_1016_j_jes_2017_10_013 crossref_primary_10_1089_thy_2018_0417 crossref_primary_10_1002_jbmr_2879 crossref_primary_10_1186_s12302_018_0139_z crossref_primary_10_1186_s12302_020_00446_y crossref_primary_10_1016_j_ijgo_2015_09_002 crossref_primary_10_1002_gch2_202300198 crossref_primary_10_1016_j_chemosphere_2017_02_146 crossref_primary_10_1016_j_jhazmat_2025_138946 crossref_primary_10_1016_j_cbi_2019_04_013 crossref_primary_10_1016_S2468_2020_16_30056_0 crossref_primary_10_1136_jech_2016_208006 crossref_primary_10_1016_j_mce_2019_110666 crossref_primary_10_1080_10408398_2019_1611539 crossref_primary_10_1186_s12302_024_00999_2 crossref_primary_10_15252_embr_201744294 crossref_primary_10_1002_admi_201902100 crossref_primary_10_1016_j_ajog_2016_01_182 crossref_primary_10_1016_j_jhazmat_2017_03_036 crossref_primary_10_2174_0929867324666170518095736 crossref_primary_10_1016_j_chemosphere_2024_142601 crossref_primary_10_1016_j_envint_2016_10_018 crossref_primary_10_3389_fgene_2020_00405 crossref_primary_10_1159_000443400 crossref_primary_10_1289_EHP10273 crossref_primary_10_3389_fmed_2025_1583203 crossref_primary_10_1136_jech_2016_207841 crossref_primary_10_3389_ftox_2022_909307 crossref_primary_10_1155_2018_6821601 crossref_primary_10_1210_en_2017_00348 crossref_primary_10_1093_toxsci_kfx133 crossref_primary_10_1007_s12595_021_00410_5 crossref_primary_10_1016_S2213_8587_21_00052_8 crossref_primary_10_1007_s11154_016_9329_4 crossref_primary_10_1186_s12940_017_0265_x crossref_primary_10_1016_j_envpol_2022_119918 crossref_primary_10_1016_j_envint_2021_106574 crossref_primary_10_1016_j_tox_2022_153255 crossref_primary_10_1210_en_2016_1342 crossref_primary_10_1016_j_totert_2023_100071 crossref_primary_10_1016_S2213_8587_16_30121_8 crossref_primary_10_1038_nrendo_2016_198 crossref_primary_10_1016_S2213_8587_20_30129_7 crossref_primary_10_1177_2053019619872808 crossref_primary_10_1136_jech_2016_208463 crossref_primary_10_1016_j_jhazmat_2020_122929 crossref_primary_10_3390_ijms21082988 crossref_primary_10_1016_j_jhazmat_2020_122020 crossref_primary_10_1186_s12302_022_00670_8 crossref_primary_10_1016_j_ecoenv_2022_113826 crossref_primary_10_1016_j_cbi_2022_109952 crossref_primary_10_1017_S0963180117000111 crossref_primary_10_1210_jc_2015_1622 crossref_primary_10_1055_a_1533_2861 crossref_primary_10_1016_j_hazadv_2022_100107 crossref_primary_10_1210_jendso_bvad141 crossref_primary_10_1186_s12940_017_0340_3 crossref_primary_10_3390_ijerph13020181 crossref_primary_10_1111_jjns_12347 crossref_primary_10_1016_j_jhazmat_2021_127327 crossref_primary_10_1111_ina_13030 crossref_primary_10_1111_joim_13748 crossref_primary_10_1016_j_ecoenv_2019_109406 crossref_primary_10_1007_s00204_019_02641_0 crossref_primary_10_1016_j_envres_2021_112415 crossref_primary_10_1016_j_neuro_2025_04_001 crossref_primary_10_1111_andr_12178 crossref_primary_10_1038_s41598_017_02885_9 crossref_primary_10_1016_j_neuint_2016_06_003 crossref_primary_10_1016_j_cbi_2017_03_001 crossref_primary_10_1038_nprot_2016_068 crossref_primary_10_3390_ijerph16061084 crossref_primary_10_1088_1755_1315_1013_1_012014 crossref_primary_10_1159_000446436 crossref_primary_10_1016_j_freeradbiomed_2022_09_024 crossref_primary_10_1289_EHP644 crossref_primary_10_3390_ijms24043296 crossref_primary_10_1038_srep42907 crossref_primary_10_3390_toxics10040181 crossref_primary_10_1038_536030d crossref_primary_10_1016_j_jhealeco_2020_102341 crossref_primary_10_1007_s11356_018_3774_4 crossref_primary_10_1016_j_tox_2017_05_004 crossref_primary_10_1093_ajcn_nqab308 crossref_primary_10_1289_EHP6047 crossref_primary_10_1007_s11154_016_9327_6 crossref_primary_10_1016_j_envpol_2017_03_021 crossref_primary_10_3390_ijms18091909 crossref_primary_10_1016_j_watres_2025_124301 crossref_primary_10_1016_j_envint_2019_02_025 crossref_primary_10_1080_10934529_2018_1530539 crossref_primary_10_1007_s10646_016_1612_3 crossref_primary_10_3917_rpre_214_0119 crossref_primary_10_1016_j_scitotenv_2019_03_258 crossref_primary_10_1016_j_jclepro_2021_126701 crossref_primary_10_1002_2017GH000119 crossref_primary_10_1177_2053019617726308 crossref_primary_10_1016_j_envint_2021_106547 crossref_primary_10_3390_su11164344 crossref_primary_10_1016_j_marenvres_2025_107143 crossref_primary_10_1021_envhealth_4c00277 crossref_primary_10_1007_s00204_017_2014_x crossref_primary_10_1016_j_ijheh_2024_114422 crossref_primary_10_1371_journal_pone_0145368 crossref_primary_10_3390_bios11020046 crossref_primary_10_3390_ijms21082954 crossref_primary_10_1016_S2213_8587_16_30279_0 crossref_primary_10_1093_eurpub_ckaa074 crossref_primary_10_1016_j_scitotenv_2021_150887 crossref_primary_10_1016_S2213_8587_15_00423_4 crossref_primary_10_1097_GCO_0000000000000373 crossref_primary_10_3389_ftox_2021_649024 crossref_primary_10_1016_j_watres_2024_122543 crossref_primary_10_1097_EDE_0000000000000525 crossref_primary_10_1016_j_mce_2020_110711 crossref_primary_10_3390_toxics10120766 crossref_primary_10_1016_j_watres_2023_120645 crossref_primary_10_1016_j_ecoenv_2024_116838 crossref_primary_10_1289_ehp_1510810 crossref_primary_10_3390_ijms26188979 crossref_primary_10_3390_w15030582 crossref_primary_10_1016_j_toxlet_2019_05_006 crossref_primary_10_1016_j_scr_2017_10_013 crossref_primary_10_1016_j_ecoenv_2019_04_045 crossref_primary_10_1016_j_envsci_2024_103694 crossref_primary_10_1289_ehp_1409535 crossref_primary_10_3390_agronomy11122494 crossref_primary_10_1007_s10661_015_4754_5 crossref_primary_10_1093_scipol_scx004 crossref_primary_10_1016_j_crvi_2017_07_006 crossref_primary_10_1186_s12940_020_00635_5 crossref_primary_10_1016_j_crvi_2017_07_008 crossref_primary_10_1016_j_scitotenv_2019_06_300 crossref_primary_10_1016_j_pmr_2022_04_010 crossref_primary_10_1007_s11356_019_05340_6 crossref_primary_10_1016_j_jclinepi_2019_03_009 crossref_primary_10_1016_j_reprotox_2016_10_001 crossref_primary_10_1016_j_scitotenv_2019_133921 crossref_primary_10_1177_1048291116666485 crossref_primary_10_3390_ijerph191610458 crossref_primary_10_1016_j_ebiom_2020_102640 crossref_primary_10_1093_aje_kwx267 crossref_primary_10_1016_j_envint_2018_12_032 crossref_primary_10_1016_j_tifs_2018_11_029 crossref_primary_10_1186_s12940_022_00858_8 crossref_primary_10_1016_j_envres_2023_115788 crossref_primary_10_3390_toxics10030146 crossref_primary_10_1038_s41591_025_03697_5 crossref_primary_10_1007_s11270_025_08343_x crossref_primary_10_1073_pnas_2412714121 crossref_primary_10_1016_j_neuint_2016_10_011 crossref_primary_10_1146_annurev_publhealth_071823_105338 crossref_primary_10_1007_s11356_015_5162_7 crossref_primary_10_3389_fendo_2024_1401120 crossref_primary_10_1289_EHP217 crossref_primary_10_1007_s00216_019_01805_2 crossref_primary_10_1016_S2213_8587_17_30316_9 crossref_primary_10_3390_w13101347 crossref_primary_10_1016_j_neubiorev_2025_106028 crossref_primary_10_1016_j_banm_2024_03_004 crossref_primary_10_1016_j_jhazmat_2018_03_032 crossref_primary_10_1016_j_envres_2025_120828 crossref_primary_10_1146_annurev_pharmtox_021921_093352 crossref_primary_10_1360_CSB_2025_0225 crossref_primary_10_1016_j_talanta_2024_125665 crossref_primary_10_1159_000504668 crossref_primary_10_1016_j_ijheh_2025_114647 crossref_primary_10_1007_s12103_016_9362_6 crossref_primary_10_1016_j_envpol_2021_118021 crossref_primary_10_1016_j_etap_2016_10_015 crossref_primary_10_1007_s11356_023_31384_w crossref_primary_10_1186_s12940_016_0156_6 crossref_primary_10_1016_j_envint_2023_108161 crossref_primary_10_3390_jox11040012 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1210/jc.2014-4324 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1945-7197 |
| ExternalDocumentID | 25742516 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -~X .55 .GJ .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 3O- 4.4 48X 53G 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABZA AACZT AAIMJ AAJQQ AAKAS AAPGJ AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABBLC ABDFA ABDPE ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABUWG ABVGC ABWST ABXVV ABXZS ACFRR ACGFO ACGFS ACPRK ACUTJ ACVCV ACYHN ACZBC ADBBV ADGKP ADGZP ADHKW ADMTO ADNBA ADQBN ADRTK ADVEK ADZCM AELWJ AEMDU AEMQT AENEX AENZO AEOTA AERZD AETBJ AEWNT AFCHL AFFNX AFFQV AFFZL AFGWE AFKRA AFOFC AFRAH AFXAL AFYAG AGINJ AGKRT AGMDO AGORE AGQXC AGUTN AHGBF AHMBA AHMMS AI. AJBYB AJDVS AJEEA ALMA_UNASSIGNED_HOLDINGS ALXQX APIBT APJGH AQDSO AQKUS ARIXL ASPBG ATGXG AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BENPR BEYMZ BPHCQ BSWAC BTRTY BVXVI C45 CCPQU CDBKE CGR CS3 CUY CVF D-I DAKXR DIK E3Z EBS ECM EIF EIHJH EJD EMOBN ENERS F5P FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FYUFA GAUVT GJXCC GX1 H13 HMCUK HVGLF HZ~ H~9 IAO IHR INH ITC J5H KBUDW KOP KSI KSN L7B M1P M5~ MBLQV MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NPM NU- NVLIB O9- OAUYM OBFPC OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO REU ROX ROZ TEORI TJX TLC TMA TR2 TWZ UKHRP VH1 VVN W8F WHG WOQ X52 X7M YBU YFH YHG YOC YSK ZGI ZXP ZY1 ~02 ~H1 7X8 AEHZK |
| ID | FETCH-LOGICAL-c5888-9c10bfb5e47aaf762f1bf29e19ec324eef4632e3457f8eafaf1ce6e79a7417512 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 257 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00004678-201504000-00008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1945-7197 |
| IngestDate | Thu Oct 02 15:42:23 EDT 2025 Mon Jul 21 05:58:48 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5888-9c10bfb5e47aaf762f1bf29e19ec324eef4632e3457f8eafaf1ce6e79a7417512 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-83769 |
| PMID | 25742516 |
| PQID | 1671216970 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1671216970 pubmed_primary_25742516 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-April |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-April |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The journal of clinical endocrinology and metabolism |
| PublicationTitleAlternate | J Clin Endocrinol Metab |
| PublicationYear | 2015 |
| References | 19433249 - Mol Cell Endocrinol. 2009 May 25;304(1-2):63-8 6942722 - Ann N Y Acad Sci. 1981;363:189-204 18665197 - J Expo Sci Environ Epidemiol. 2009 Feb;19(2):223-34 10984369 - J Allergy Clin Immunol. 2000 Sep;106(3):493-9 18613034 - Birth Defects Res B Dev Reprod Toxicol. 2008 Jun;83(3):157-395 10929856 - Med Decis Making. 2000 Jul-Sep;20(3):332-42 3102916 - Milbank Q. 1986;64(4):489-547 18941581 - Environ Health Perspect. 2008 Oct;116(10):1376-82 14283879 - Proc R Soc Med. 1965 May;58:295-300 20562054 - Environ Health Perspect. 2010 Oct;118(10):1444-9 12777573 - Pediatrics. 2003 Jun;111(6 Pt 1):1467-74 10548101 - Nature. 1999 Oct 21;401(6755):763-4 17105985 - J Natl Cancer Inst. 2006 Nov 15;98(22):1623-33 23963708 - Obesity (Silver Spring). 2014 Feb;22(2):488-96 11413183 - J Epidemiol Community Health. 2001 Jul;55(7):508-14 15840436 - Toxicology. 2005 Jun 1;210(2-3):223-33 8849754 - JAMA. 1996 Oct 16;276(15):1253-8 25742518 - J Clin Endocrinol Metab. 2015 Apr;100(4):1278-88 11294977 - Toxicol Sci. 2001 May;61(1):76-82 21676388 - Environ Res. 2011 Aug;111(6):825-30 12088877 - Mol Cell Endocrinol. 2002 Jun 28;192(1-2):157-70 19433246 - Mol Cell Endocrinol. 2009 May 25;304(1-2):43-8 17119266 - Ann N Y Acad Sci. 2006 Sep;1076:911-23 21259266 - Mt Sinai J Med. 2011 Jan-Feb;78(1):98-106 11836195 - Am J Epidemiol. 2002 Feb 15;155(4):313-22 18619930 - Econ Hum Biol. 2008 Jul;6(2):281-92 15205295 - BMJ. 2004 Jun 19;328(7454):1490 6923138 - Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429-62 18483053 - BMJ. 2008 May 17;336(7653):1106-10 21924589 - Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79 15498886 - Endocrinology. 2005 Feb;146(2):607-12 20403173 - BMC Health Serv Res. 2010 Apr 19;10:97 15615589 - BMC Health Serv Res. 2004 Dec 22;4(1):38 22147869 - Health Aff (Millwood). 2011 Dec;30(12):2400-9 3082226 - Am J Public Health. 1986 Apr;76(4):392-6 25454231 - Environ Int. 2015 Jan;74:144-51 12356922 - Occup Environ Med. 2002 Oct;59(10):651-2 1434963 - Med Care. 1992 Nov;30(11 Suppl):NS1-12 21478780 - Med Care. 2011 Aug;49(8):679-85 16804814 - Semin Reprod Med. 2006 Jul;24(3):156-67 9019804 - Science. 1997 Jan 24;275(5299):463 15198913 - Environ Health Perspect. 2004 Jun;112(9):944-9 25742517 - J Clin Endocrinol Metab. 2015 Apr;100(4):1267-77 25742515 - J Clin Endocrinol Metab. 2015 Apr;100(4):1256-66 24177261 - Toxicol Lett. 2013 Dec 16;223(3):295-305 10468437 - Epidemiology. 1999 Sep;10(5):573-84 17938728 - Environ Health Perspect. 2007 Oct;115(10):1406-14 22733974 - Endocrinology. 2012 Sep;153(9):4097-110 8922972 - Health Econ. 1996 Sep-Oct;5(5):447-67 23473920 - Environ Res. 2013 May;123:17-24 21543421 - Health Aff (Millwood). 2011 May;30(5):863-70 22990270 - JAMA. 2012 Sep 19;308(11):1113-21 |
| References_xml | – reference: 15205295 - BMJ. 2004 Jun 19;328(7454):1490 – reference: 19433249 - Mol Cell Endocrinol. 2009 May 25;304(1-2):63-8 – reference: 21259266 - Mt Sinai J Med. 2011 Jan-Feb;78(1):98-106 – reference: 8922972 - Health Econ. 1996 Sep-Oct;5(5):447-67 – reference: 3082226 - Am J Public Health. 1986 Apr;76(4):392-6 – reference: 15615589 - BMC Health Serv Res. 2004 Dec 22;4(1):38 – reference: 23963708 - Obesity (Silver Spring). 2014 Feb;22(2):488-96 – reference: 22147869 - Health Aff (Millwood). 2011 Dec;30(12):2400-9 – reference: 6923138 - Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429-62 – reference: 15198913 - Environ Health Perspect. 2004 Jun;112(9):944-9 – reference: 11836195 - Am J Epidemiol. 2002 Feb 15;155(4):313-22 – reference: 22990270 - JAMA. 2012 Sep 19;308(11):1113-21 – reference: 8849754 - JAMA. 1996 Oct 16;276(15):1253-8 – reference: 16804814 - Semin Reprod Med. 2006 Jul;24(3):156-67 – reference: 10984369 - J Allergy Clin Immunol. 2000 Sep;106(3):493-9 – reference: 24177261 - Toxicol Lett. 2013 Dec 16;223(3):295-305 – reference: 25742515 - J Clin Endocrinol Metab. 2015 Apr;100(4):1256-66 – reference: 25742517 - J Clin Endocrinol Metab. 2015 Apr;100(4):1267-77 – reference: 25742518 - J Clin Endocrinol Metab. 2015 Apr;100(4):1278-88 – reference: 10548101 - Nature. 1999 Oct 21;401(6755):763-4 – reference: 9019804 - Science. 1997 Jan 24;275(5299):463 – reference: 17119266 - Ann N Y Acad Sci. 2006 Sep;1076:911-23 – reference: 21478780 - Med Care. 2011 Aug;49(8):679-85 – reference: 3102916 - Milbank Q. 1986;64(4):489-547 – reference: 18941581 - Environ Health Perspect. 2008 Oct;116(10):1376-82 – reference: 20403173 - BMC Health Serv Res. 2010 Apr 19;10:97 – reference: 17938728 - Environ Health Perspect. 2007 Oct;115(10):1406-14 – reference: 17105985 - J Natl Cancer Inst. 2006 Nov 15;98(22):1623-33 – reference: 21924589 - Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79 – reference: 18483053 - BMJ. 2008 May 17;336(7653):1106-10 – reference: 20562054 - Environ Health Perspect. 2010 Oct;118(10):1444-9 – reference: 15840436 - Toxicology. 2005 Jun 1;210(2-3):223-33 – reference: 12088877 - Mol Cell Endocrinol. 2002 Jun 28;192(1-2):157-70 – reference: 21676388 - Environ Res. 2011 Aug;111(6):825-30 – reference: 12356922 - Occup Environ Med. 2002 Oct;59(10):651-2 – reference: 12777573 - Pediatrics. 2003 Jun;111(6 Pt 1):1467-74 – reference: 22733974 - Endocrinology. 2012 Sep;153(9):4097-110 – reference: 1434963 - Med Care. 1992 Nov;30(11 Suppl):NS1-12 – reference: 6942722 - Ann N Y Acad Sci. 1981;363:189-204 – reference: 11294977 - Toxicol Sci. 2001 May;61(1):76-82 – reference: 14283879 - Proc R Soc Med. 1965 May;58:295-300 – reference: 19433246 - Mol Cell Endocrinol. 2009 May 25;304(1-2):43-8 – reference: 25454231 - Environ Int. 2015 Jan;74:144-51 – reference: 18619930 - Econ Hum Biol. 2008 Jul;6(2):281-92 – reference: 23473920 - Environ Res. 2013 May;123:17-24 – reference: 11413183 - J Epidemiol Community Health. 2001 Jul;55(7):508-14 – reference: 10468437 - Epidemiology. 1999 Sep;10(5):573-84 – reference: 15498886 - Endocrinology. 2005 Feb;146(2):607-12 – reference: 18613034 - Birth Defects Res B Dev Reprod Toxicol. 2008 Jun;83(3):157-395 – reference: 10929856 - Med Decis Making. 2000 Jul-Sep;20(3):332-42 – reference: 21543421 - Health Aff (Millwood). 2011 May;30(5):863-70 – reference: 18665197 - J Expo Sci Environ Epidemiol. 2009 Feb;19(2):223-34 |
| SSID | ssj0014453 |
| Score | 2.6002808 |
| Snippet | Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.
The objective was to... Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.CONTEXTRapidly... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1245 |
| SubjectTerms | Adult Aged Attention Deficit Disorder with Hyperactivity - chemically induced Attention Deficit Disorder with Hyperactivity - economics Attention Deficit Disorder with Hyperactivity - epidemiology Autistic Disorder - chemically induced Autistic Disorder - economics Autistic Disorder - epidemiology Child Cost of Illness Endocrine Disruptors - toxicity Endocrine System Diseases - economics Endocrine System Diseases - epidemiology Environmental Exposure - economics Environmental Exposure - statistics & numerical data Environmental Pollutants - toxicity European Union - economics European Union - statistics & numerical data Female Humans Male Middle Aged |
| Title | Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25742516 https://www.proquest.com/docview/1671216970 |
| Volume | 100 |
| WOSCitedRecordID | wos00004678-201504000-00008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPAabPpImpOI7OLBXfagsLeSZieih7TaXfHnO2mz7EkQvPTU0DIzmfnmTcgNGCGT2GqWqDJiiG-BoZ1JmAVIZSxytMgtp5_keJxPp2oSAm5NKKtc6sRWUc8q42Pkt1xIHnOhZHRXfzC_NcpnV8MKjXXSSxDKeKmW01UWIU3bKZTop2dMciVD4bvvWnn34wt5yvxAut_BZWtkhrv__b09shPgJb3v5GGfrIE7IFujkEA_JK8DvNIepLpXWrYdDFS7GQ1pGmqqZt7QylL4risfO6TzioLDz_smQYavfS7q9rAJgwYa-uYogki6DOvThUNWH5GX4eD54ZGFXQvMZOgEM2V4VNoyQw5pbVFDWl7aWAFXYJBEADYVSQxJmkmbg7bacgMCpNIISSSihmOy4SoHp4TmOouMFaVCBzUFoRES8NSK3HI5Q2so-uR6ScICZdknKLSDatEUKyL2yUnHh6Luhm4UqFpQvXBx9ofT52QbmZt1BTYXpGeRGnBJNs3XHOl01QoJPseT0Q_9_Mei |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimating+burden+and+disease+costs+of+exposure+to+endocrine-disrupting+chemicals+in+the+European+union&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Trasande%2C+Leonardo&rft.au=Zoeller%2C+R+Thomas&rft.au=Hass%2C+Ulla&rft.au=Kortenkamp%2C+Andreas&rft.date=2015-04-01&rft.issn=1945-7197&rft.eissn=1945-7197&rft.volume=100&rft.issue=4&rft.spage=1245&rft_id=info:doi/10.1210%2Fjc.2014-4324&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1945-7197&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1945-7197&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1945-7197&client=summon |